Work

A phase II study of nilotinib administered to patients with imatinib resistant or intolerant chronic myelogenous leukemia (CML) in chronic phase (CP), accelerated phase (AP) or blast crisis (BC) who also failed dasatinib

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.7038

Authors: F. J. Giles, P. le Coutre, K. Bhalla, G. Rosti, G. Ossenkoppele, G. Alimena, A. Weitzman, M. Zheng, H. Kantarjian

Institutions: Policlinico Umberto I, Moffitt Cancer Center, Amsterdam UMC Location Vrije Universiteit Amsterdam

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2537035463

Cites:

Cited by: 14

Related to: 10